- Home
-
Research
Development -
Community
Engagement -
Scientific
Translation -
Human
Studies -
Informatics
Biostatistics -
Education
Training -
Research
Ethics -
Regulatory
Support
|
|
|
Through transformation of our highly successful GCRC at USC and satellite Unit at CHLA, one of the largest programs in the nation, we will provide the CTSI and CTSI researchers the ability to translate important discoveries of novel therapeutic, diagnostic, and mechanistic approaches to improve health and health care for the diverse Los Angeles urban population. We will serve as the nexus for clinical testing and for the training of new clinical investigators in an environment of unparalleled participant, staff, and community diversity.
We will transform clinical research through our newly expanded and renovated Clinical Trials Units at USC and CHLA by providing important new services for clinical researchers and greater opportunity to translate laboratory discoveries; by promoting studies in community settings; by providing assistance/training in Good Clinical Practices and standards of ethical conduct of research; and by providing financial resources through the CTSI Pilot Grant Program.
Dr. Sattler is a Professor of Medicine and Biokinesiology and Chief of Infectious Diseases at USC Keck School of Medicine (KSOM) and serves as CHS Director. He has served as the Associate Program Director of the USC General Clinical Research Center (GCRC) since 1996. He is PI of the ACTG Clinical Trials Unit at USC (U01A127673) and Principal Investigator (PI) of a multicenter clinical and translational study titled Hormonal Regulators of Muscle and Metabolism in Aging (R01AG18169). He conducts other investigator-initiated clinical and translational research in aging. He formerly served as the Chair of the NIAID/ACTG Opportunistic Infections Committee and has held other important leadership positions in the ACTG over the past two decades.
Dr. El-Khoueiry is Assistant Professor of Medicine at USC in the Division of Medical Oncology and serves as CHS Co-director for Adult Studies. He is the Phase I Program Director of the USC Norris Comprehensive Cancer Center, a member of the NCI Hepatobiliary Cancer Task Force, and Medical Director of the Clinical Investigations Support Office (CISO) for the USC Cancer Center. As Director of CISO, he has reorganized its administrative processes for greater operational efficiency while remaining highly productive in Phase I development of new cancer therapies. Dr. El-Khoueiry brings excellent expertise to the CHS Leadership Team.
Dr. Gomperts is a Professor of Clinical Pediatrics and Pathology, Director of Clinical Research, and Director of the GCRC at Children’s Hospital Los Angeles (CHLA) and serves as CHS Co-director of Pediatric Trials. He has over 30 years experience in academia, with 20 years experience in funded clinical research. He also has extensive translational experience having worked in ‘industry’ as the Vice President for Global Medical Affairs and Clinical Development in the Bioscience Division of Baxter Healthcare for 15 years.
Ms. Hurtado is the President and CEO of the USC Health Resources Association (HRA), a study organization to assist researchers with IRB proposals, IND/IDE submissions and management, compliance oversight, and Good Clinical Practices (GCPs). Ms. Hurtado serves as CHS Co-director for Industry Releations and Clinical Trials Support. She is skilled in the coordination of training in regulatory operations, quality assurance and subject safety, and in developing new collaborations between USC investigators and private sponsors for investigator-initiated research.